Joachim Grötzinger mainly investigates Cell biology, Glycoprotein 130, Molecular biology, Signal transduction and Biochemistry. His biological study spans a wide range of topics, including Interleukin-17 receptor, Leukemia inhibitory factor receptor, Ligand, Receptor complex and Ciliary neurotrophic factor. His Glycoprotein 130 study combines topics from a wide range of disciplines, such as Common gamma chain, Protein subunit, Receptor, Interleukin-3 receptor and Interleukin-6 receptor.
His Molecular biology research is multidisciplinary, incorporating elements of Polymerase, Carcinogenesis, Alpha chain, STAT3 and Interleukin 10. He works mostly in the field of Signal transduction, limiting it down to topics relating to Interleukin 6 and, in certain cases, In vivo. His work in the fields of Biochemistry, such as Peptide sequence, Binding protein and Escherichia coli, overlaps with other areas such as Mycobacterium bovis.
Biochemistry, Glycoprotein 130, Cell biology, Molecular biology and Receptor are his primary areas of study. His Glycoprotein 130 study integrates concerns from other disciplines, such as Interleukin-6 receptor, Cytokine receptor and Fusion protein. In his study, Transmembrane protein is inextricably linked to Disintegrin, which falls within the broad field of Cell biology.
His study in Molecular biology is interdisciplinary in nature, drawing from both Antibody, Monoclonal antibody and Receptor complex. His Receptor research incorporates themes from Epitope, Stereochemistry and Cytokine. His work deals with themes such as Interleukin and Protein subunit, which intersect with Signal transduction.
His primary areas of study are Cell biology, Molecular biology, Disintegrin, Biochemistry and Metalloproteinase. His research in Cell biology is mostly concerned with Signal transduction. His studies in Molecular biology integrate themes in fields like Myocyte, Histone acetyltransferase, Interleukin-6 receptor and Receptor complex.
The Biochemistry study combines topics in areas such as Aptamer and Interleukin-6 receptor binding. Joachim Grötzinger interconnects Glycoprotein 130, Phosphorylation and Stereochemistry in the investigation of issues within Receptor. His Glycoprotein 130 research is within the category of Interleukin 6.
His main research concerns Cell biology, ADAM17 Protein, Sheddase, Metalloproteinase and Disintegrin. His research integrates issues of Serine, Proteases, Cell membrane, Interleukin-6 receptor and Signal transduction in his study of ADAM17 Protein. His studies deal with areas such as Cleavage, Immunology, Neutrophil elastase, Fusion protein and Interleukin as well as Signal transduction.
His Disintegrin study is concerned with the larger field of Biochemistry. His research in Biochemistry intersects with topics in Aptamer and Interleukin-6 receptor binding. His research in Downregulation and upregulation focuses on subjects like Cell, which are connected to Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structural basis of calcification inhibition by α2-HS glycoprotein/fetuin-A - Formation of colloidal calciprotein particles
Alexander Heiss;Alexander DuChesne;Bernd Denecke;Joachim Grötzinger.
Journal of Biological Chemistry (2003)
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Martina Fischer;Jutta Goldschmitt;Christian Peschel;Just P. G. Brakenhoff.
Nature Biotechnology (1997)
The IL-6/sIL-6R complex as a novel target for therapeutic approaches.
Stefan Rose-John;Georg H Waetzig;Jürgen Scheller;Joachim Grötzinger.
Expert Opinion on Therapeutic Targets (2007)
Differential Activation of Acute Phase Response Factor/Stat3 and Stat1 via the Cytoplasmic Domain of the Interleukin 6 Signal Transducer gp130 II. Src HOMOLOGY SH2 DOMAINS DEFINE THE SPECIFICITY OF STAT FACTOR ACTIVATION
Ulrike Hemmann;Claudia Gerhartz;Birgit Heesel;Jürgen Sasse.
Journal of Biological Chemistry (1996)
Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
Erwan Mortier;Erwan Mortier;Agnès Quéméner;Agnès Quéméner;Patricia Vusio;Inken Lorenzen.
Journal of Biological Chemistry (2006)
Plasticity and cross-talk of interleukin 6-type cytokines.
Christoph Garbers;Heike M. Hermanns;Fred Schaper;Gerhard Müller-Newen.
Cytokine & Growth Factor Reviews (2012)
Molecular Determinants of KCNQ (Kv7) K+ Channel Sensitivity to the Anticonvulsant Retigabine
Anne Schenzer;Thomas Friedrich;Michael Pusch;Paul Saftig.
The Journal of Neuroscience (2005)
Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defence.
Thomas C.G. Bosch;René Augustin;Friederike Anton-Erxleben;Sebastian Fraune.
Developmental and Comparative Immunology (2009)
The Nucleotide-Binding Oligomerization Domain-Like Receptor NLRC5 Is Involved in IFN-Dependent Antiviral Immune Responses
Sven Kuenzel;Andreas Till;Michael Winkler;Robert Häsler.
Journal of Immunology (2010)
Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A.
Sunke Himpel;Pascal Panzer;Klaus Eirmbter;Hanna Czajkowska.
Biochemical Journal (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: